Related references
Note: Only part of the references are listed.Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis
Costantino Ricci et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)
Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis
Costantino Ricci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2022)
SOX2 and PRAME in the reprogramming of seminoma cells
Agnese Orsatti et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34
Costantino Ricci et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms
Marco Grillini et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2021)
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study
Costantino Ricci et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Utility of ERG Immunohistochemistry for Evaluation of Lymphovascular Invasion in Testicular Germ Cell Tumors: A Retrospective Pilot Study
Aaron M. Udager et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2019)
Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas
Joao Lobo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Testicular Cancer, Version 2.2020
Timothy Gilligan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
F. Honecker et al.
ANNALS OF ONCOLOGY (2018)
Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited
J. Aparicio
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel
Joost L. Boormans et al.
EUROPEAN UROLOGY (2018)
Reporting and Staging of Testicular Germ Cell Tumors The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations
Clare Verrill et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors
Karin Purshouse et al.
CLINICAL GENITOURINARY CANCER (2017)
Do Histopathologic Variables Affect the Reporting of Lymphovascular Invasion in Testicular Germ Cell Tumors?
Bryce L. French et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Disparities in Interpretation of Primary Testicular Germ Cell Tumor Pathology
Pranav Sharma et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists
Daniel M. Berney et al.
HISTOPATHOLOGY (2015)
Microvascular Invasion of Testicular Nonseminomatous Germ Cell Tumors: Implications of Separate Evaluation of Lymphatic and Blood Vessels
Julia Heinzelbecker et al.
JOURNAL OF UROLOGY (2014)
Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors
Pei Dong et al.
MEDICAL ONCOLOGY (2013)
Difficult Differential Diagnoses in Testicular Pathology
Huihui Ye et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Concordance and Prediction Ability of Original and Reviewed Vascular Invasion and Other Prognostic Parameters of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors After Retroperitoneal Lymph Node Dissection
Nicola Nicolai et al.
JOURNAL OF UROLOGY (2011)
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy
C. Kollmannsberger et al.
ANNALS OF ONCOLOGY (2010)
Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: Results of the German Testicular Cancer Study Group Trial
P Albers et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
